Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Several factors are putting downward pressure on GLP-1 prices
It is an experimental compound not approved for human clinical use
Semaglutide is a peptide and a GLP-1 agonist, meaning it attaches to GLP-1 receptors, stimulating them
Market growth is driven by the rising adoption of digital garage operations, cloud-based workshop platforms, automated billing, service scheduling, inventory tracking, Semaglutide API Market Growth Outlook, Key Drivers, Challenges, Demand Trends, Innovation, and Investment Opportunities The Semaglutide API market is experiencing robust growth driven by increasing prevalence of type 2 diabetes and obesity, which are primary indications for Semaglutide-based therapies
US$ 22.48
US$ 28.03
US$ 28.98
